Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

UGT1A1 Polymorphism and Mortality Outcome after Allogeneic Stem Cell Transplantation with Busulfan Based Regimen

Patrizia Chiusolo, Angelo Minucci, Metafuni Elisabetta, Sabrina Giammarco, MD PhD, Monica Rossi, Gessica Minnella, Cecilia Zuppi, Andrea Urbani, Andrea Bacigalupo, MD, Ettore Capoluongo, Simona Sica, MD

Blood (2017) 130 (Supplement 1): 3218.

https://doi.org/10.1182/blood.V130.Suppl_1.3218.3218

Published: 2017

Journal Articles

Irinotecan Induces Complete Remission in MLL -Rearranged Acute Lymphoblastic Leukemia Xenografts

Patricia Garrido Castro, PhD, Mark Kerstjens, MSc, Sandra S Pinhanços, MSc, Pauline Schneider, BSc, Priscilla Wander, MSc, Rob Pieters, MD PhD, Ronald Stam, PhD

Blood (2017) 130 (Supplement 1): 3877.

https://doi.org/10.1182/blood.V130.Suppl_1.3877.3877

Published: 2017

Journal Articles

Drug-Induced Immune Thrombocytopenia (DITP) Caused By Multiple Drug-Dependent Platelet-Reactive Antibodies (DDAbs) in Patients Undergoing Oxaliplatin-Containing Combination Chemotherapy for Metastatic Colon Cancer

Brian R. Curtis, PhDMT(ASCP), Yen-Michael S. Hsu, MD PhD, Nikolai A. Podoltsev, MD PhD, Jill Lacy, MD, Susanna A Curtis, MD, Robert Andrew Desimone, MD, Michael Samuel, MD, Kristin Zutavern, BS, Daniel Bougie, PhD, Richard H. Aster, MD

Blood (2017) 130 (Supplement 1): 3625.

https://doi.org/10.1182/blood.V130.Suppl_1.3625.3625

Published: 2017

Journal Articles

Effects of Chemotherapy on Extracellular Vesicles and Coagulation Activation in Colorectal Cancer Patients: A Pilot Study

Ludwig Traby, MD, Hannah C. Puhr, Marietta Kollars, Kammer Michael, Gerald Prager, MD, Werner Scheithauer, MD, Gabriela Kornek, MD, Paul Alexander Kyrle, MD, Sabine Eichinger, MD

Blood (2016) 128 (22): 1425.

https://doi.org/10.1182/blood.V128.22.1425.1425

Published: 2016

Journal Articles

Risk Factors for Venous Thromboembolism in Metastatic Colon Cancer Patients in the Contemporary Treatment Era: A SEER-Medicare Data Analysis

Bhargavi Pulluri, MD, Benjamin Littenberg, MD, Inder Lal, MD, Chris E. HOlmes, MD PhD, Steven Ades, MD MSc

Blood (2016) 128 (22): 2598.

https://doi.org/10.1182/blood.V128.22.2598.2598

Published: 2016

Journal Articles

A New Antibody-Drug Conjugate Composed of an Anti-HLA-DR IgG4 Antibody, IMMU-114, and SN-38, Is Active in Experimental Acute Myelocytic Leukemia (AML), Acute Lymphocytic Leukemia (ALL), and Multiple Myeloma (MM)

David M Goldenberg, ScD, MD, Robert M Sharkey, Ph.D., Serengulam V Govindan, PhD, Maria Zalath, BA, Ali Mostafa, BS, Thomas M Cardillo, Ph.D.

Blood (2016) 128 (22): 3958.

https://doi.org/10.1182/blood.V128.22.3958.3958

Published: 2016

Journal Articles

Less Toxic Gemcitabine-Oxaliplatin Based Induction Regimen (R-GIDIOX) Prior to Autologous SCT Produces Outcomes Similar to High-Dose Cytarabine Containing Intensive Induction Regimen in Mantle Cell Lymphoma – a Follow up Report of the Multicenter Study

Vladimir I. Vorobyev, MD PhD, Sergei K. Kravchenko, MD PhD, Eduard G. Gemdzhian, PhD, Jana K. Mangasarova, MD PhD, Elena Baryakh, MDPhD, Alla M. Kovrigina, MD PhD Prof., Tatiana N. Obukhova, PhD, Kamil Kaplanov, Egor I. Dubrovin, MD, Ivan A Vorobjev, Prof., Natalya G. Turina, MD PhD, Valeri G. Savchenko, MD Prof.

Blood (2014) 124 (21): 1726.

https://doi.org/10.1182/blood.V124.21.1726.1726

Published: 2014

Journal Articles

Acute Leukemias Following a Diagnosis of Colorectal Cancer: Are They Therapy-Related?

Eytan M. Stein, MD, Vipul Pareek, MD, David Kudlowitz, Dan Douer, MD, Martin S Tallman, MD

Blood (2012) 120 (21): 1453.

https://doi.org/10.1182/blood.V120.21.1453.1453

Published: 2012

Journal Articles

Intensive Induction, Autologous Stem Cell Transplantation and Rituximab Maintenance Has Changed Event Free Survival and Overall Survival in Mantle Cell Lymphoma Patients. Using Gemcitabine and Oxaliplatin in First Line Therapy

Vladimir I. Vorobyev, MD, Yuri Yu. Lorie, MD, PhD, Evgenii' E. Zvonkov, MD, PhD, Eduard G. Gemdjian, PhD, Aminat U. Magomedova, MD, PhD, Anait L. Melikyan, MD, PhD, Jana K. Mangasarova, MD, PhD, Elena O. Gribanova, MD, PhD, Vera A. Zherebtsova, MD, PhD, Sergey K. Kravchenko, MD, PhD, Valeri G. Savchenko, MD, PhD

Blood (2012) 120 (21): 2034.

https://doi.org/10.1182/blood.V120.21.2034.2034

Published: 2012

Journal Articles

Effectiveness of Transcriptional CDK Inhibitors in Targeting Non-Proliferating CD34+CD38- AML Cells,

Monica Pallis, PhD, Francis Burrows, PhD, Abigail Whittall, B Med Sci, Claire Seedhouse, PhD, Nicholas Boddy, B Med Sci, Nigel H. Russell, MD

Blood (2011) 118 (21): 3482.

https://doi.org/10.1182/blood.V118.21.3482.3482

Published: 2011

Journal Articles

Romiplostim in a Case Series of Chemotherapy-Induced Thrombocytopenia

Rekha Parameswaran, MD, Gerald A. Soff, MD

Blood (2011) 118 (21): 1170.

https://doi.org/10.1182/blood.V118.21.1170.1170

Published: 2011

Journal Articles

Epratuzumab (Humanized Anti-CD22 MAb) Conjugated with SN-38, a New Antibody-Drug Conjugate (ADC) for the Treatment of Hematologic Tumors: Preclinical Studies Alone and In Combination with Veltuzumab, a Humanized Anti-CD20 MAb

David M Goldenberg, Sc.D., M.D., Serengulam Govindan, Ph.D., Tom M Cardillo, Ph.D., Robert M Sharkey, Ph.D.

Blood (2010) 116 (21): 3941.

https://doi.org/10.1182/blood.V116.21.3941.3941

Published: 2010

Journal Articles

B-Cell Lymphoma Cells Overexpressing BMI-1 Are Correlated with Drug Resistance through Enhanced Expression of Survivin and Are Effectively Eliminated by T Cells with Anti-CD38 Chimeric Receptor

Joyeeta Bhattacharyya, Keichiro Mihara, MD, PhD, Motoaki Ohtsubo, Shin'ichiro Yasunaga, MD, PhD, Yoshihiro Takihara, MD, PhD, Masaharu Hoshi, Akiro Kimura, MD, PhD

Blood (2010) 116 (21): 3613.

https://doi.org/10.1182/blood.V116.21.3613.3613

Published: 2010

Journal Articles

Cisplatin-Based Chemotherapy Is Associated with An Unacceptably High Incidence of Thromboembolic Events: A Large Retrospective Analysis.

Russell A. Moore, PharmD, Nelly G. Adel, PharmD, Manisha Bhutani, MD, Nour Elise Tabbara, Heather Landau, MD, Stephen D Nimer, MD, Darren R. Feldman, MD, Hani Hassoun, MD

Blood (2009) 114 (22): 456.

https://doi.org/10.1182/blood.V114.22.456.456

Published: 2009

Journal Articles

Irinotecan and Increased Triglyceride Level in Paraneoplastic Deep Venous Thrombosis (DVT): A Strange Link in An Old Problem

Giulio Giordano, MD, Giuliana Farina, MD, Rosa Tambaro, Silvia Piano, MD, Stefano Papini, MD, Bruno Zappacosta, Ph.D, Sergio Storti, MD

Blood (2008) 112 (11): 5356.

https://doi.org/10.1182/blood.V112.11.5356.5356

Published: 2008

Journal Articles

Targeting the Bcl-2 Family of Proteins in Hodgkin Lymphoma: In Vitro Cytotoxicity, Target Modulation and Drug Combination Studies of the BH3 Mimetic ABT-737

Aarthi Jayanthan, BS, Scott C Howard, MD, Tanya Trippett, MD, Terzah M. Horton, MD, PhD, Lara Daisley, Victor A. Lewis, MD, Aru Narendran, MD., Ph.D

Blood (2008) 112 (11): 3626.

https://doi.org/10.1182/blood.V112.11.3626.3626

Published: 2008

Journal Articles

Preclinical Results of the Camptothecin-Polymer Conjugate IT-101 in Multiple Human Lymphoma Xenografts.

Tontanai Numbenjapon, MD, Jianyi Wang, MD, David Colcher, PhD, Thomas Schluep, ScD, Mark E. Davis, PhD, Julienne Duringer, BS, Stephen J. Forman, MD, Andrew Raubitschek, MD

Blood (2007) 110 (11): 1376.

https://doi.org/10.1182/blood.V110.11.1376.1376

Published: 2007

Journal Articles

Assessment of Thrombotic Risk in Cancer Patients: Proposal of a Scoring System. A Monocentric Study.

Giulio Giordano, MD, Giuliana Farina, MD, Tambaro Rosa, MD, Silvia Piano, MD, Monica Specchia, MD, Stefano Papini, MD, Piero Modugno, MD, Enrico Maria Centritto, MD, Bruno Zappacosta, MD, Sergio Storti, MD

Blood (2007) 110 (11): 3991.

https://doi.org/10.1182/blood.V110.11.3991.3991

Published: 2007

Journal Articles

2006 RADAR Report Card on Conversion Rates from Accelerated FDA Approval to Regular FDA Approval for Drugs Used To Treat Hematologic Malignancies: Policy Changes Continue To Be Needed.

Andrew J. Lurie, BGS, Mark V. Mai, Martin S. Tallman, MD, June McCoy, MD JD MPH, Charles L. Bennett, MD PhD MPP

Blood (2006) 108 (11): 3318.

https://doi.org/10.1182/blood.V108.11.3318.3318

Published: 2006

Journal Articles

Overexpression of Carboxylesterase-2 Results in Enhanced Efficacy of Topoisomerase I Inhibitor, Irinotecan (CPT-11), for Refractory Multiple Myeloma.

Hiroki Yano, MD, Satoshi Kayukawa, M.D., Shinsuke Iida, M.D., Chiharu Nakagawa, Ph.D., Takaomi Sanda, M.D. Ph.D., Shigeru Kusumoto, M.D., Takashi Ishida, M.D. Ph.D., Hirokazu Komatsu, M.D., Atsushi Suzuki, Ph.D., Ryuzo Ueda, M.D.

Blood (2006) 108 (11): 5107.

https://doi.org/10.1182/blood.V108.11.5107.5107

Published: 2006

NARROW

UGT1A1 Polymorphism and Mortality Outcome after Allogeneic Stem Cell Transplantation with Busulfan Based Regimen

Irinotecan Induces Complete Remission in MLL -Rearranged Acute Lymphoblastic Leukemia Xenografts

Drug-Induced Immune Thrombocytopenia (DITP) Caused By Multiple Drug-Dependent Platelet-Reactive Antibodies (DDAbs) in Patients Undergoing Oxaliplatin-Containing Combination Chemotherapy for Metastatic Colon Cancer

Effects of Chemotherapy on Extracellular Vesicles and Coagulation Activation in Colorectal Cancer Patients: A Pilot Study

Risk Factors for Venous Thromboembolism in Metastatic Colon Cancer Patients in the Contemporary Treatment Era: A SEER-Medicare Data Analysis

A New Antibody-Drug Conjugate Composed of an Anti-HLA-DR IgG4 Antibody, IMMU-114, and SN-38, Is Active in Experimental Acute Myelocytic Leukemia (AML), Acute Lymphocytic Leukemia (ALL), and Multiple Myeloma (MM)

Less Toxic Gemcitabine-Oxaliplatin Based Induction Regimen (R-GIDIOX) Prior to Autologous SCT Produces Outcomes Similar to High-Dose Cytarabine Containing Intensive Induction Regimen in Mantle Cell Lymphoma – a Follow up Report of the Multicenter Study

Acute Leukemias Following a Diagnosis of Colorectal Cancer: Are They Therapy-Related?

Intensive Induction, Autologous Stem Cell Transplantation and Rituximab Maintenance Has Changed Event Free Survival and Overall Survival in Mantle Cell Lymphoma Patients. Using Gemcitabine and Oxaliplatin in First Line Therapy

Effectiveness of Transcriptional CDK Inhibitors in Targeting Non-Proliferating CD34+CD38- AML Cells,

Romiplostim in a Case Series of Chemotherapy-Induced Thrombocytopenia

Epratuzumab (Humanized Anti-CD22 MAb) Conjugated with SN-38, a New Antibody-Drug Conjugate (ADC) for the Treatment of Hematologic Tumors: Preclinical Studies Alone and In Combination with Veltuzumab, a Humanized Anti-CD20 MAb

B-Cell Lymphoma Cells Overexpressing BMI-1 Are Correlated with Drug Resistance through Enhanced Expression of Survivin and Are Effectively Eliminated by T Cells with Anti-CD38 Chimeric Receptor

Cisplatin-Based Chemotherapy Is Associated with An Unacceptably High Incidence of Thromboembolic Events: A Large Retrospective Analysis.

Irinotecan and Increased Triglyceride Level in Paraneoplastic Deep Venous Thrombosis (DVT): A Strange Link in An Old Problem

Targeting the Bcl-2 Family of Proteins in Hodgkin Lymphoma: In Vitro Cytotoxicity, Target Modulation and Drug Combination Studies of the BH3 Mimetic ABT-737

Preclinical Results of the Camptothecin-Polymer Conjugate IT-101 in Multiple Human Lymphoma Xenografts.

Assessment of Thrombotic Risk in Cancer Patients: Proposal of a Scoring System. A Monocentric Study.

2006 RADAR Report Card on Conversion Rates from Accelerated FDA Approval to Regular FDA Approval for Drugs Used To Treat Hematologic Malignancies: Policy Changes Continue To Be Needed.

Overexpression of Carboxylesterase-2 Results in Enhanced Efficacy of Topoisomerase I Inhibitor, Irinotecan (CPT-11), for Refractory Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only